BRIEF-Bergenbio Presents Update On Selective AXL
Dec 11 (Reuters) - BERGENBIO ASA:
* BERGENBIO PRESENTS UPDATE ON PH II CLINICAL TRIAL WITH SELECTIVE AXL
* ‍CLINICAL BENEFIT WAS OBSERVED AND THREE NOVEL, PROPRIETARY PREDICTIVE BIOMARKER CANDIDATES WERE IDENTIFIED​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)